Margitta Worm Selected Research

Antigens

11/2022	S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid.
1/2021	Vitamin A controls the allergic response through T follicular helper cell as well as plasmablast differentiation.
11/2016	Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans.
10/2013	Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Margitta Worm Research Topics

Disease

73	Hypersensitivity (Allergy) 03/2024 - 02/2002
64	Anaphylaxis (Anaphylactic Shock) 12/2023 - 01/2010
40	Atopic Dermatitis (Atopic Eczema) 01/2024 - 11/2002
25	Food Hypersensitivity (Food Allergy) 04/2024 - 09/2002
20	Eczema 11/2023 - 01/2003
20	Asthma (Bronchial Asthma) 01/2023 - 10/2004
13	Inflammation (Inflammations) 03/2024 - 10/2009
12	COVID-19 01/2023 - 01/2020
10	Dermatitis 01/2024 - 09/2008
9	Allergic Rhinitis 01/2024 - 04/2012
9	Systemic Scleroderma (Systemic Sclerosis) 01/2023 - 08/2010
8	Bullous Pemphigoid (Pemphigoid) 03/2024 - 07/2015
7	Skin Diseases (Skin Disease) 03/2024 - 10/2011
7	Contact Dermatitis (Eczema, Contact) 01/2022 - 03/2007
6	Pemphigus (Pemphigus Vulgaris) 12/2023 - 07/2015
6	Allergic Contact Dermatitis 01/2022 - 02/2007
5	Seasonal Allergic Rhinitis (Hay Fever) 01/2019 - 11/2002
4	Bites and Stings (Sting) 01/2023 - 03/2002
4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 11/2013
3	Localized Scleroderma (Morphea) 03/2024 - 09/2009
3	Pain (Aches) 10/2023 - 03/2007
3	Urticaria (Hives) 12/2022 - 09/2002
3	Neoplasms (Cancer) 11/2022 - 11/2018
3	Immediate Hypersensitivity 11/2022 - 10/2009
3	Infections 03/2022 - 01/2013
3	Pruritus (Itching) 10/2021 - 09/2005
3	Disease Susceptibility (Diathesis) 01/2021 - 09/2007
3	Chronic Urticaria 11/2020 - 02/2002
3	Drug Hypersensitivity (Drug Allergy) 01/2020 - 01/2019
2	Overweight 12/2023 - 01/2014
2	Dermatomyositis (Dermatopolymyositis) 10/2023 - 10/2022
2	Mastocytosis 01/2023 - 01/2020
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023 - 12/2017
2	Angioedema 11/2022 - 01/2003
2	Body Weight (Weight, Body) 10/2022 - 01/2020
2	Headache (Headaches) 10/2022 - 01/2022
2	Nasopharyngitis 01/2022 - 01/2016
2	Cutaneous Lupus Erythematosus 11/2021 - 01/2021
2	Communicable Diseases (Infectious Diseases) 10/2021 - 01/2012
2	Syphilis 04/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

52	AllergensIBA 04/2024 - 01/2006
32	Immunoglobulin E (IgE)IBA 04/2024 - 03/2002
28	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023 - 01/2012
12	dupilumabIBA 03/2024 - 01/2016
11	Arthropod VenomsIBA 12/2023 - 05/2014
11	VaccinesIBA 01/2023 - 01/2011
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2004
10	VenomsIBA 01/2023 - 03/2002
8	COVID-19 VaccinesIBA 01/2023 - 01/2021
8	AutoantibodiesIBA 01/2020 - 01/2011
8	CytokinesIBA 12/2016 - 10/2003
6	Interleukin-13IBA 03/2024 - 03/2013
6	Immunoglobulin G (IgG)IBA 12/2023 - 07/2011
6	Tryptases (Tryptase)IBA 01/2023 - 11/2019
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 09/2005
5	TabletsIBA 01/2024 - 12/2007
5	Peptides (Polypeptides)IBA 01/2018 - 01/2009
4	NickelIBA 12/2023 - 01/2012
4	Immunoglobulin A (IgA)IBA 11/2023 - 10/2009
4	LigandsIBA 11/2023 - 10/2003
4	tralokinumabIBA 11/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
4	Histamine Antagonists (Antihistamines)IBA 01/2023 - 01/2012
4	AntigensIBA 11/2022 - 10/2013
4	Matrix Metalloproteinases (MMPs)IBA 11/2022 - 07/2015
4	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 01/2009
4	4'-N,N-dimethylamino-4-aminoazobenzeneIBA 01/2021 - 01/2014
4	OvalbuminIBA 11/2013 - 10/2003
3	Intravenous Immunoglobulins (IVIG)FDA Link 10/2023 - 10/2020
3	Collagen Type XVIIIBA 11/2022 - 01/2019
3	Messenger RNA (mRNA)IBA 11/2022 - 01/2021
3	Irritants (Vesicants)IBA 01/2022 - 09/2007
3	Vitamin D FDA LinkGeneric 01/2022 - 08/2014
3	Penicillins (Penicillin)FDA Link 04/2021 - 01/2020
3	BNT162 VaccineIBA 02/2021 - 01/2021
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 02/2015
3	Monoclonal AntibodiesIBA 01/2020 - 01/2016
3	Rituximab (Mabthera)FDA Link 01/2019 - 07/2015
2	InterleukinsIBA 03/2024 - 01/2016
2	VitaminsIBA 11/2023 - 01/2022
2	Glutens (Glutelin)IBA 10/2023 - 01/2018
2	mRNA VaccinesIBA 01/2023 - 11/2022
2	Bee Venoms (Bee Venom)IBA 01/2023 - 05/2014
2	anti-IgE antibodiesIBA 01/2023 - 01/2021
2	Omalizumab (Xolair)FDA Link 01/2023 - 01/2023
2	Excipients (Suspending Agents)IBA 01/2023 - 10/2021
2	Food Additives (Food Additive)IBA 11/2022 - 02/2002
2	Thymic Stromal LymphopoietinIBA 01/2022 - 01/2019
2	Air Pollutants (Pollutants, Air)IBA 01/2022 - 01/2014
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2021 - 01/2016
2	Therapeutic UsesIBA 01/2021 - 01/2014

Therapy/Procedure

48	Therapeutics 03/2024 - 03/2002
20	Immunotherapy 03/2024 - 05/2010
5	Injections 10/2021 - 05/2010
4	Drug Therapy (Chemotherapy) 01/2024 - 01/2014
4	Emergency Treatment 10/2023 - 01/2014
3	Critical Care (Surgical Intensive Care) 01/2021 - 01/2014
3	Secondary Prevention 01/2020 - 01/2012
2	Gluten-Free Diet 10/2023 - 01/2018
2	Cesarean Section (Caesarean Section) 01/2022 - 01/2014